申请人:ImmuneSensor Therapeutics, Inc.
公开号:US10947206B2
公开(公告)日:2021-03-16
Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.
所公开的是作为 cGAS 拮抗剂的新型式 I 化合物、该化合物的制备方法、包含该化合物的药物组合物及其在医学治疗中的用途。